Search
for
Sort by
Research 121–150 of 347
- Acquired scalp alopecia. Part I: A review
- Scarring Alopecia
- Primary cicatricial alopecias
- Cosmetic Considerations in Dark-Skinned Patients
- Acne-Associated Syndromes
- Westwood Carolina Conference on Clinical Dermatology
- Clinical Management in Psychodermatology
- Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- Successful treatment of epidermal growth factor receptor inhibitor–induced alopecia with doxycycline
- Scalp Pustule as a Manifestation of Erlotinib-Induced Skin Toxicity: Report of Two Cases and Literature Review
- FREQUENCY OF SKIN MANIFESTATIONS IN PATIENTS ON CHEMOTHERAPY
- “Arrow” sign: A rapid microscopic diagnosis of hair change associated with epidermal growth factor receptor inhibitors
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Ponatinib-induced pityriasis rubra pilaris-like adnexal dysmaturation: A case report
- Zoonotic Majocchi's Granuloma of the Vulva.
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Trichoscopic Findings of Erosive Pustular Dermatosis of the Scalp Associated with Gefitinib
- Mucocutaneous findings in hematolymphoid neoplasms: An observational study
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- A case of rosacea fulminans during pregnancy with review of the literature
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Skin Manifestations of Rheumatological Diseases
- The red face: Rosacea
- Dermatological problems of the puberty
- Lepidoptera Lexicon: Metaphorical Descriptors in Dermatology
- Acne Necrotica in Its Entirety: When It Starts, and After It Evolves
- Persistent hair growth during treatment with the EGFR inhibitor erlotinib
- Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin
- Erlotinib-Induced Skin Inflammation Is IL-1 Mediated in KC-Tie2 Mice and Human Skin Organ Culture
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies